LKQ vs LXRX · P/E 14, rev $6.88B vs rev $21.8M
LKQ Corporation (LKQ) versus Lexicon Pharmaceuticals Inc (LXRX) — a side-by-side from cached financials, not a winner call.
LKQ Corporation (LKQ) is a auto parts company listed on US.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Latest reported LKQ revenue for 2026-06-30 was $6.88B. Net income was $215.0M. Revenue was up 98.2% from 2026-03-31 to 2026-06-30. LKQ currently screens at market cap $9.99B and trailing P/E 14.4.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
LKQ currently screens at market cap $9.99B and trailing P/E 14.4. LXRX currently screens at market cap $327.2M.
Not investment advice. Open the LKQ and LXRX stock pages for the full models.
Not investment advice.